logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong stock market anomaly | MedEase Technology (02158.HK) rises by over 5%, AI medical field is expected to further expand, the company achieves full scenario solution implementation.

date
21/05/2025
According to the Securities Times app, Yidu Tech (02158.HK) has risen by more than 5%, with an increase of 5.13% to HKD 5.94 as of the time of writing, with a turnover of HKD 70.9584 million.
Latest
2 m ago
Xinkaipu: The actual controller, Yang Weiguo, received a decision letter from the Public Security Bureau to revoke the case.
3 m ago
The average price of new houses in Shanghai Huangpu is 18,500 yuan per square meter, with Sunlight becoming the first single project in the country to exceed 10 billion yuan in luxury homes this year.
3 m ago
Hanghua Group (688571.SH): Xiefeng Investment plans to inquire about transferring 2.6% of the company's shares.
3 m ago
China General Nuclear Power (01816.HK) will distribute a final dividend of HKD 0.095 per share on July 3rd.
4 m ago
Kolon Pharmaceutical: Subsidiary's Injection of Biperiden/Sodium Chloride Injection Solution Obtains Drug Registration Approval.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.